{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:01:43Z","timestamp":1793948503807,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:00:00Z","timestamp":1689465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:00:00Z","timestamp":1689465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12308-023-00554-7","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T03:13:37Z","timestamp":1689477217000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma\u2014presentation in novel settings and comprehensive review of literature"],"prefix":"10.1007","volume":"16","author":[{"given":"Alireza","family":"Ghezavati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7954-6740","authenticated-orcid":false,"given":"Alia","family":"Nazarullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,16]]},"reference":[{"issue":"8","key":"554_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/00000478-199908000-00017","volume":"23","author":"MM Velankar","year":"1999","unstructured":"Velankar MM, Nathwani BN, Schlutz MJ, Bain LA, Arber DA, Slovak ML, Weiss LM (1999) Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy. Am J Surg Pathol 23(8):977\u2013981. https:\/\/doi.org\/10.1097\/00000478-199908000-00017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"554_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/PAP.0b013e31828d17ec","volume":"20","author":"RS Ohgami","year":"2013","unstructured":"Ohgami RS, Arber DA, Zehnder JL, Natkunam Y, Warnke RA (2013) Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma. Adv Anat Pathol 20(3):137\u2013140. https:\/\/doi.org\/10.1097\/PAP.0b013e31828d17ec","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"554_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3346\/jkms.2010.25.2.309","volume":"25","author":"S Eun","year":"2010","unstructured":"Eun S, Jeon YK, Jang JJ (2010) Hepatocellular carcinoma with immature T-cell (T-lymphoblastic) proliferation. J Korean Med Sci 25(2):309\u2013312. https:\/\/doi.org\/10.3346\/jkms.2010.25.2.309","journal-title":"J Korean Med Sci"},{"issue":"11","key":"554_CR4","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1097\/PAS.0b013e318264e223","volume":"36","author":"RS Ohgami","year":"2012","unstructured":"Ohgami RS, Zhao S, Ohgami JK, Leavitt MO, Zehnder JL, West RB, Arber DA, Natkunam Y, Warnke RA (2012) TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 36(11):1619\u20131628. https:\/\/doi.org\/10.1097\/PAS.0b013e318264e223","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"554_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/(SICI)1096-9896(199907)188:3<267::AID-PATH357>3.0.CO;2-N","volume":"188","author":"E Pilozzi","year":"1999","unstructured":"Pilozzi E, M\u00fcller-Hermelink HK, Falini B, de Wolf-Peeters C, Fidler C, Gatter K, Wainscoat J (1999) Gene rearrangements in T-cell lymphoblastic lymphoma. J Pathol 188(3):267\u2013270. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199907)188:3%3c267::AID-PATH357%3e3.0.CO;2-N","journal-title":"J Pathol"},{"issue":"11","key":"554_CR6","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1080\/10428190600822151","volume":"47","author":"ZM Wang","year":"2006","unstructured":"Wang ZM, Xiao WB, Zheng SS, Sun K, Wang LJ (2006) Hepatocellular carcinoma with indolent T-lymphoblastic proliferation. Leuk Lymphoma 47(11):2424\u20132426. https:\/\/doi.org\/10.1080\/10428190600822151","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"554_CR7","first-page":"1674","volume":"11","author":"M Kong","year":"2018","unstructured":"Kong M, Wang Z, Teng X, Xu L, Liu J, Jiang C, Teng L (2018) Hepatic carcinoma with indolent T-lymphoblastic proliferation (iT-LBP). Int J Clin Exp Pathol 11(3):1674\u20131678","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"554_CR8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/his.14176","volume":"77","author":"N Brar","year":"2020","unstructured":"Brar N, Butzmann A, Kumar J, Peerani R, Morgan EA, Grigoriadis G, Kumar B, Tatarczuch RM, Warnke RA, Ohgami RS (2020) LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia\/lymphoma from indolent T-lymphoblastic proliferations. Histopathology 77(6):984\u2013988. https:\/\/doi.org\/10.1111\/his.14176","journal-title":"Histopathology"},{"issue":"1","key":"554_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.humpath.2009.05.014","volume":"41","author":"WY Kim","year":"2010","unstructured":"Kim WY, Kim H, Jeon YK, Kim CW (2010) Follicular dendritic cell sarcoma with immature T cell proliferation. Hum Pathol 41(1):129\u2013133. https:\/\/doi.org\/10.1016\/j.humpath.2009.05.014","journal-title":"Hum Pathol"},{"issue":"2","key":"554_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/ajcp\/aqv024","volume":"145","author":"D Jevremovic","year":"2016","unstructured":"Jevremovic D, Roden AC, Ketterling RP, Kurtin PJ, McPhail ED (2016) LMO2 is a specific marker of T-lymphoblastic leukemia\/lymphoma. Am J Clin Pathol 145(2):180\u2013190. https:\/\/doi.org\/10.1093\/ajcp\/aqv024","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"554_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1084\/jem.182.3.759","volume":"182","author":"K Sato","year":"1995","unstructured":"Sato K, Ohtsuka K, Hasegawa K, Yamagiwa S, Watanabe H, Asakura H, Abo T (1995) Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med 182(3):759\u2013767. https:\/\/doi.org\/10.1084\/jem.182.3.759","journal-title":"J Exp Med"},{"issue":"6","key":"554_CR12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1034\/j.1600-0609.2000.90158.x","volume":"64","author":"T Shimizu","year":"2000","unstructured":"Shimizu T, Bannai M, Kawamura H, Yamamoto S, Oya H, Maruyama S, Minagawa M, Kawamura T, Watanabe H, Hatakeyama K, Abo T (2000) Organ specificity of c-kit+ lymphoid precursors in the liver, thymus, and bone marrow. Eur J Haematol 64(6):416\u2013425. https:\/\/doi.org\/10.1034\/j.1600-0609.2000.90158.x","journal-title":"Eur J Haematol"},{"issue":"6","key":"554_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1348-0421.1999.tb02446.x","volume":"43","author":"T Shimizu","year":"1999","unstructured":"Shimizu T, Sugahara S, Oya H, Maruyama S, Minagawa M, Bannai M, Hatakeyama K, Abo T (1999) The majority of lymphocytes in the bone marrow, thymus and extrathymic T cells in the liver are generated in situ from their own preexisting precursors. Microbiol Immunol 43(6):595\u2013608. https:\/\/doi.org\/10.1111\/j.1348-0421.1999.tb02446.x","journal-title":"Microbiol Immunol"},{"issue":"3","key":"554_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00000478-200103000-00018","volume":"25","author":"JA Strauchen","year":"2001","unstructured":"Strauchen JA (2001) Indolent T-lymphoblastic proliferation: report of a case with an 11-year history and association with myasthenia gravis. Am J Surg Pathol 25(3):411\u2013415. https:\/\/doi.org\/10.1097\/00000478-200103000-00018","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"554_CR15","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/10428190802645079","volume":"50","author":"YW Qian","year":"2009","unstructured":"Qian YW, Weissmann D, Goodell L, August D, Strair R (2009) Indolent T-lymphoblastic proliferation in Castleman lymphadenopathy. Leuk Lymphoma 50(2):306\u2013308. https:\/\/doi.org\/10.1080\/10428190802645079","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"554_CR16","first-page":"6350","volume":"7","author":"F Yang","year":"2014","unstructured":"Yang F, Liu T, Zhao H, Hu Z, Xiao L, Liu Y, Wang X, Li Z (2014) Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract. Int J Clin Exp Pathol 7(9):6350\u20136356","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"554_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.pathol.2017.09.017","volume":"50","author":"AE Quesada","year":"2018","unstructured":"Quesada AE, Young KH, Medeiros LJ, Thakral B (2018) Indolent T-lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and Castleman disease. Pathology 50(3):351\u2013352. https:\/\/doi.org\/10.1016\/j.pathol.2017.09.017","journal-title":"Pathology"},{"issue":"4","key":"554_CR18","first-page":"1497","volume":"12","author":"J Chen","year":"2019","unstructured":"Chen J, Feng J, Xiao H, Ma Q, Chen Z (2019) Indolent T-lymphoblastic proliferation associated with Castleman disease and low grade follicular dendric cell sarcoma: report of a case and review of literature. Int J Clin Exp Pathol 12(4):1497\u20131505","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"554_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/his.13433","volume":"72","author":"H Yasuda","year":"2018","unstructured":"Yasuda H, Tsutsui M, Ota Y, Tanaka M, Komatsu N (2018) Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review. Histopathology 72(5):862\u2013866. https:\/\/doi.org\/10.1111\/his.13433","journal-title":"Histopathology"},{"issue":"9","key":"554_CR20","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1097\/PAS.0000000000000197","volume":"38","author":"RS Ohgami","year":"2014","unstructured":"Ohgami RS, Sendamarai AK, Atwater SK, Liedtke M, Fleming MD, Natkunam Y, Warnke RA (2014) Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression. Am J Surg Pathol 38(9):1298\u20131304. https:\/\/doi.org\/10.1097\/PAS.0000000000000197","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"554_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.humpath.2015.03.007","volume":"46","author":"R Kansal","year":"2015","unstructured":"Kansal R, Nathwani BN, Yiakoumis X, Moschogiannis M, Sachanas S, Stefanaki K, Pangalis GA (2015) Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease. Hum Pathol 46(7):1057\u20131061. https:\/\/doi.org\/10.1016\/j.humpath.2015.03.007","journal-title":"Hum Pathol"},{"issue":"12","key":"554_CR22","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1097\/PAS.0000000000001158","volume":"42","author":"M Walters","year":"2018","unstructured":"Walters M, Pittelkow MR, Hasserjian RP, Harris NL, Macon WR, Kurtin PJ, Rech KLG (2018) Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome. Am J Surg Pathol 42(12):1647\u20131652. https:\/\/doi.org\/10.1097\/PAS.0000000000001158","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"554_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.annpat.2018.09.003","volume":"39","author":"B Chauveau","year":"2019","unstructured":"Chauveau B, Le Loarer F, Bacci J, Baylac F, Dubus P, Ling C, Parrens M (2019) Maladie de Castleman localis\u00e9e avec prolif\u00e9ration lymphoblastique T indolente [Indolent T-lymphoblastic proliferation in association with localized Castleman disease: a case report]. Ann Pathol 39(1):29\u201335. https:\/\/doi.org\/10.1016\/j.annpat.2018.09.003","journal-title":"Ann Pathol"},{"key":"554_CR24","doi-asserted-by":"publisher","first-page":"1724083","DOI":"10.1155\/2019\/1724083","volume":"2019","author":"E Moughames","year":"2019","unstructured":"Moughames E, Kiess AP, Akst LM, Azar A (2019) Sirolimus for the treatment of airway obstruction due to indolent T-lymphoblastic proliferation. Case Reports in Immunology 2019:1724083. https:\/\/doi.org\/10.1155\/2019\/1724083","journal-title":"Case Reports in Immunology"},{"issue":"5","key":"554_CR25","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00428-021-03184-5","volume":"480","author":"Z Yuanyuan","year":"2022","unstructured":"Yuanyuan Z, Jianlan X, Yanlin Z, Xiaoge Z (2022) Indolent T-lymphoblastic proliferation: a report of three cases. Virchows Archiv\u202f: An Int J Pathol 480(5):1121\u20131126. https:\/\/doi.org\/10.1007\/s00428-021-03184-5","journal-title":"Virchows Archiv : An Int J Pathol"},{"issue":"1","key":"554_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4132\/jptm.2014.11.17","volume":"49","author":"CG Woo","year":"2015","unstructured":"Woo CG, Huh J (2015) TdT+ T-lymphoblastic proliferation in Castleman disease. J Pathol Transl Med 49(1):1\u20134. https:\/\/doi.org\/10.4132\/jptm.2014.11.17","journal-title":"J Pathol Transl Med"},{"issue":"5","key":"554_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/PAS.0b013e3181d7a2ee","volume":"34","author":"M Hartert","year":"2010","unstructured":"Hartert M, Str\u00f6bel P, Dahm M, Nix W, Marx A, Vahl CF (2010) A follicular dendritic cell sarcoma of the mediastinum with immature T cells and association with myasthenia gravis. Am J Surg Pathol 34(5):742\u2013745. https:\/\/doi.org\/10.1097\/PAS.0b013e3181d7a2ee","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"554_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/cyto.b.21845","volume":"98","author":"JR Fromm","year":"2020","unstructured":"Fromm JR, Edlefsen KL, Cherian S, Wood BL, Soma L, Wu D (2020) Flow cytometric features of incidental indolent T lymphoblastic proliferations. Cytometry B Clin Cytom 98(3):282\u2013287. https:\/\/doi.org\/10.1002\/cyto.b.21845","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-023-00554-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-023-00554-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-023-00554-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:03:26Z","timestamp":1721088206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-023-00554-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,16]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1007\/s12308-023-00554-7","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,16]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}